Is the Label Skinny Enough?
April 2022
In this podcast, Finnegan attorneys Mark Feldstein, Cora Holt, and Tom Irving discuss the impacts of the recent Federal Circuit cases GSK v. Teva and Amarin v. Hikma.
A closed captioning version is available here.
Tags
United States Court of Appeals for the Federal Circuit (CAFC), drugs, Food and Drug Administration (FDA)
